Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Bernard Fisher, John Bryant, Norman Wolmark et al. · Journal of Clinical Oncology · 1998 · 2.2K citations

Medicine, Oncology, Surgery +17

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Henry M. Kuerer, Lisa A. Newman, Terry L. Smith et al. · Journal of Clinical Oncology · 1999 · 1.3K citations

Medicine, Oncology, Surgery +17

The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

Harry D. Bear, Stewart Anderson, Ann Brown et al. · Journal of Clinical Oncology · 2003 · 1.1K citations

Medicine, Oncology, Surgery +17

Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27

Harry D. Bear, Stewart Anderson, Roy E. Smith et al. · Journal of Clinical Oncology · 2006 · 948 citations · Full text

Medicine, Oncology, Surgery +17

Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer

Donald A. Berry, Constance Cirrincione, I. Craig Henderson et al. · JAMA · 2006 · 731 citations · Full text

Medicine, Endocrinology, Oncology +17